Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,123 across all filing types
Latest filing 2025-06-24 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a letter dated June 24, 2025 from PegBio Co., Ltd. informing shareholders of the new electronic dissemination arrangement for corporate communications under HKEX Listing Rule 2.07A. It is not an annual or interim report, not a management discussion, not proxy materials for voting, and not announcing financial results or capital actions. Instead, it is a regulatory announcement to shareholders about how future corporate materials will be delivered. This does not fit into any specialized category except the general “Regulatory Filings” fallback (RNS).
2025-06-24 English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Report Publication Announcement Classification · 1% confidence The document is a notice to non-registered shareholders informing them that all future “Corporate Communications” (annual report, interim report, notices of meeting, circulars, proxy forms, etc.) will be published electronically on the Company’s and HKExnews websites instead of by printed copy. It does not itself contain financial statements, management discussion, or proxy solicitation for a specific meeting, nor is it a board change, dividend notice, or legal filing. It is an announcement regarding the publication/dissemination method of future reports (“Corporate Communications”), matching the definition of a Report Publication Announcement (RPA).
2025-06-24 English
Articles of Association
Governance Information Classification · 1% confidence The document is the full Articles of Association of PegBio Co., Ltd., detailing corporate governance rules, board and management structures, shareholder meeting procedures, share issuance and transfer provisions, audit and financial systems, and internal organizational bylaws. This aligns with Governance Information, covering the company’s internal rules and governance practices rather than a financial report, announcement, or other filing.
2025-06-20 English
Amendments to the Articles of Association
Governance Information Classification · 1% confidence The document is an official announcement of amendments to the Company’s Articles of Association following its H‐share listing. It details changes to the corporate constitution (Articles), referencing Rule 13.51(1) of the Hong Kong Listing Rules, and provides the full text availability. This is not a management change notice, financial report, or proxy statement, but rather a governance‐related document outlining the company’s internal rules. Therefore it best fits Governance Information (CGR).
2025-06-20 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 1% confidence The document is a Form FF305 “Next Day Disclosure Return” under Hong Kong Listing Rules, detailing changes in issued shares – specifically the conversion of unlisted shares into H shares and the resulting opening/closing balances. This is not an AGM presentation, earnings release, management discussion, or regulatory announcement of publication, but rather a direct report of a share issuance/capital structure change. This matches the definition for Share Issue/Capital Change (SHA).
2025-06-05 English
DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF BONDS
Capital/Financing Update Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement regarding CMBC Capital Holdings Limited’s acquisition of bonds in the OTC market, with detailed transaction terms, Listing Rules implications, and definitions. It is not a full financial report or earnings release, nor a mere notice of publication, but a transaction announcement relating to financing activities. This aligns with the “Capital/Financing Update” category (CAP).
2025-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.